ClinicalTrials.Veeva

Menu
F

Frenova Renal Research | New Jersey Kidney Care, LLC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LNP023
ANG-3070
Povetacicept
BI 685509

Parent organization

This site is a part of Frenova Renal Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who h...

Enrolling
Primary IgA Nephropathy
Drug: LNP023

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept
Locations recently updated

The study is designed as a multicenter, randomized, double-blind, placebo controlled study to demonstrate the superiority of iptacopan (LNP023) at a...

Active, not recruiting
IgA Nephropathy
Drug: Placebo
Drug: LNP023

Trial sponsors

Novartis logo
A
Boehringer Ingelheim logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems